Desk›Healthcare› Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd
BSE 506197 · NSE BLISSGVS · ISIN INE416D01022 · Group T · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹559.10
-2.05%
BSE close, 28 August 2026
₹5,940.10 cr
10.6 cr shares · Small cap
₹3,696.23 cr
as published
51.8× · 5.79×
EPS ₹10.79 · BV ₹96.56
729.81 / 96.87
₹ cr, as filed
32
5 selected · 16%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -7.0% |
|---|---|
| Against 52-week low | +372.4% |
| Day change | -2.05% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹10.79 |
|---|---|
| Price / earnings | 51.82× |
| Price / book | 5.79× |
| Book value — derived, price ÷ P/B | ₹96.56 |
| Return on equity | 11.17% |
| Operating margin | 27.36% |
| Net margin | 17.43% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 11.17%
- ROE as published
- 11.17%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 221.59 | 38.62 | 3.65 | 27.36% | 17.43% |
| Mar-26 · Q | 211.54 | 32.42 | 3.06 | 25.44% | 15.33% |
| FY25-26 | 729.81 | 96.87 | 9.17 | 24.06% | 13.27% |
Quarter on quarter
- Revenue, quarter on quarter
- +4.8%
- Net profit, quarter on quarter
- +19.1%
- Operating margin, quarter on quarter
- +192 bps
Disclosure profile 32 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 2 |
| Change in Control | 1 |
| KMP | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| General | 6 |
| Newspaper Publication | 5 |
| SAST | 4 |
| Postal Ballot | 3 |
| Board Meeting | 2 |
| ESOP Allotment | 2 |
| Meeting Update | 2 |
| Compliance Certificate | 1 |
| Outcome | 1 |
| Trading Window | 1 |
| Procedural sub-total | 27 |
| Total | 32 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
32 filings · 5 selected · busiest 2026-09-28
Filing rhythm · the twelve most recent
2026-09-222026-10-06
SelectedProcedural
Filings
32 in the window · 18 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
6 October 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
1 October 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
Please find enclosed herewith the outcome of the Board Meeting held today i.e. Thursday, October 01, 2026 through Video Conferencing or Other Audio Visual Means.
Board Meeting / Outcome of Board Meeting View filing →
-
1 October 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anupam Rasayan India Ltd
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
29 September 2026 ·
Closure of Trading Window
Please find enclosed herewith the Intimation for the Closure of the Trading Window w.e.f. Thursday, October 01, 2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
28 September 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, October 01, 2026
Bliss GVS Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2026 ,inter alia, to consider and approve Please find enclosed herewith ....
Board Meeting / Board Meeting View filing →
-
28 September 2026 ·
Meeting Updates
Please find enclosed herewith the Outcome of the 2nd Board Meeting held on September 28, 2026 at shorter Notice regarding re-classification from the "Promoter and Promoter Group" category ....
Company Update / Meeting Updates View filing →
-
28 September 2026 ·
Meeting Updates
Please find enclosed herewith the Outcome of the 1st Board Meeting held on September 28, 2026 at shorter Notice pursuant to the consummation of the transaction contemplated in the share ....
Company Update / Meeting Updates View filing →
-
28 September 2026 ·
Change in Management Control
Please find enclosed herewith the Outcome of the Board Meeting held on September 28, 2026 pursuant to the Change in Control of the Company.
Company Update / Change in Management Control View filing →
-
28 September 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").
Please find enclosed herewith Outcome of Board Meeting held on September 28, 2026, pursuant to the consummation of the transaction contemplated in the share purchase agreement dated May 23, 2026.
Others / Outcome without intimation View filing →
-
22 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Please find enclosed herewith the outcome of the Postal Ballot along with the Scrutinizer's Report and Voting Results.
AGM/EGM / Postal Ballot View filing →
-
22 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please find enclosed herewith the Disclosure of Voting Results of the Postal Ballot along with the Scrutinizer's Report.
AGM/EGM / Postal Ballot View filing →
-
4 September 2026 ·
Allotment of ESOP / ESPS
We would like to inform you that the ESOP Allotment Committee of the Company at its meeting held on today i.e. September 04, 2026 has approved the allotment of 55,250 equity shares of ....
Company Update / Allotment of ESOP / ESPS View filing →
-
2 September 2026 ·
Post-Offer Advertisement
SBI Capital Markets Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post-Offer Advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of ....
Company Update / General View filing →
-
25 August 2026 ·
Newspaper Publication
Please find enclosed herewith the Newspaper Publication regarding the extension of the Special Window for Re-Lodgement of Transfer Request of Physical Shares.
Company Update / Newspaper Publication View filing →
-
21 August 2026 ·
Newspaper Publication
Please find enclosed herewith the Newspaper Publication regarding the publication of the advertisement for the Postal Ballot Notice.
Company Update / Newspaper Publication View filing →
-
20 August 2026 ·
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find enclosed herewith the Postal Ballot Notice ("Notice") dated August 12, 2026, alongwith the Explanatory Statement for seeking approval of Members of the Company by way of remote ....
AGM/EGM / Postal Ballot View filing →
-
14 August 2026 ·
Newspaper Publication
Please find enclosed herewith the copies of newspaper advertisement published regarding the extract of statement of Un-audited Standalone and Consolidated Financial Results of the Company ....
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019
Please find enclosed herewith the outcome of Members of the Nomination and Remuneration Committee of Bliss GVS Pharma Limited ("the Company")in its meeting held today i.e. on August 12, ....
Company Update / General View filing →
-
12 August 2026 ·
Outcome Of Board Meeting Held On Wednesday, August 12, 2026
We wish to inform you that the Board Meeting of the Company was held today i.e. on Wednesday, August 12, 2026 through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") with ....
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12, 2026
We wish to inform you that the Board Meeting of the Company was held today i.e. on Wednesday, August 12, 2026, through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM"), with ....
Board Meeting / Outcome of Board Meeting View filing →
-
11 August 2026 ·
Allotment of ESOP / ESPS
We would like to inform you that the ESOP Allotment Committee of the Company at its meeting held today i.e. August 11, 2026 has approved the allotment of 31, 250 equity shares of the face ....
Company Update / Allotment of ESOP / ESPS View filing →
-
11 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
5 August 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, August 12, 2026
Bliss GVS Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Board Meeting / Board Meeting View filing →
-
27 July 2026 ·
Pre-Offer Advertisement & Corrigendum to Detailed Public Statement
SBI Capital Markets Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of ....
Company Update / General View filing →
-
24 July 2026 ·
Cessation
Please find attached detailed intimation regarding resignation of Mr. Sachin Saboo, Senior Management Personnel of the Company, pursuant to Regulation 30 of SEBI (Listing Obligations and ....
Company Update / Cessation View filing →
-
23 July 2026 ·
Newspaper Publication
Please find attached copies of the newspaper publications containing recommendation of the Committee of Independent Directors.
Company Update / Newspaper Publication View filing →
-
23 July 2026 ·
Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend 2018-2019 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) Authority
Please find enclosed herewith the Notice sent to shareholders w.r.t. the transfer of Unclaimed Final Dividend 2018-2019 and its corresponding shares to the IEPF Authority.
Company Update / General View filing →
-
22 July 2026 ·
Intimation Of Recommendations By The Committee Of Independent Directors ('IDC') Pursuant To Regulation 26(7) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Please find attached the intimation of recommendations by the Committee of Independent Directors pursuant to Regulation 26(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) ....
Company Update / General View filing →
-
22 July 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Clarus Capital I & Others
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
22 July 2026 ·
Newspaper Publication
Please find enclosed herewith the Newspaper publication regarding Notice to Shareholders for Transfer of Unclaimed Final Dividend 2018-2019 and its corresponding Equity Shares to IEPF.
Company Update / Newspaper Publication View filing →
-
21 July 2026 ·
Letter Of Offer Dated July 18, 2026 Received From SBI Capital Markets Limited
Letter of Offer dated July 18, 2026 received from SBI Capital Markets Limited, the manager to the Open Offer appointed by Anupam Rasayan India Limited along with PAC.
Company Update / General View filing →
RSS feed for Bliss GVS Pharma Ltd · the 50 most recent filings